Teladoc Health (TDOC) Research & Development (2016 - 2026)
Teladoc Health's Research & Development history spans 13 years, with the latest figure at $67.9 million for Q1 2026.
- On a quarterly basis, Research & Development fell 2.99% to $67.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $275.8 million, a 6.77% decrease, with the full-year FY2025 number at $277.9 million, down 9.55% from a year prior.
- Research & Development hit $67.9 million in Q1 2026 for Teladoc Health, down from $71.6 million in the prior quarter.
- Over the last five years, Research & Development for TDOC hit a ceiling of $89.9 million in Q4 2023 and a floor of $67.6 million in Q3 2025.
- Historically, Research & Development has averaged $78.5 million across 5 years, with a median of $78.7 million in 2022.
- Biggest five-year swings in Research & Development: rose 13.81% in 2022 and later decreased 14.66% in 2024.
- Tracing TDOC's Research & Development over 5 years: stood at $82.9 million in 2022, then increased by 8.45% to $89.9 million in 2023, then fell by 14.66% to $76.8 million in 2024, then decreased by 6.7% to $71.6 million in 2025, then decreased by 5.23% to $67.9 million in 2026.
- Business Quant data shows Research & Development for TDOC at $67.9 million in Q1 2026, $71.6 million in Q4 2025, and $67.6 million in Q3 2025.